Hemodynamic pressure sensing with Abbott’s CardioMEMS HF system can significantly reduce the risk of death from heart failure. That’s according to a meta-analysis of three randomized, controlled trials that Abbott presented today at the Technology and Heart Failure Therapeutics (THT) Conference in Boston. The data comes from an analysis evaluating CardioMEMS HF in heart failure … Continue reading Study says heart failure survival improves with Abbott CardioMEMS monitoring tech